Design and Synthesis of Some New Benzoylthioureido Phenyl Derivatives Targeting Carbonic Anhydrase Enzymes
Overview
Authors
Affiliations
The present study aimed to develop potent carbonic anhydrase inhibitors (CAIs). The design of the target compounds was based on modifying the structure of the ureido-based carbonic anhydrase inhibitor SLC-0111. Six series of a substituted benzoylthioureido core were prepared featuring different zinc-binding groups; the conventional sulphamoyl group and , its bioisosteric carboxylic acid group and or the ethyl carboxylate group and as potential prodrugs. All compounds were assessed for their carbonic anhydrase (CA) inhibitory activity against a panel of four physiologically relevant human CA isoforms hCA I and hCA II, and hCA IX, and hCA XII. Compounds , , , , and revealed significant inhibitory activity against hCA I that would highlight these compounds as promising drug candidates for the treatment of glaucoma.
Thanh N, Toan V, Trang V RSC Med Chem. 2025; .
PMID: 39823041 PMC: 11734695. DOI: 10.1039/d4md00816b.
Carbonic anhydrase inhibitory activity of phthalimide-capped benzene sulphonamide derivatives.
Shilkar D, Siddique M, Bua S, Yasmin S, Patil M, Timiri A J Enzyme Inhib Med Chem. 2023; 38(1):2235089.
PMID: 37439360 PMC: 10348020. DOI: 10.1080/14756366.2023.2235089.
Kugler M, Hadzima M, Dzijak R, Rampmaier R, Srb P, Vrzal L RSC Med Chem. 2023; 14(1):144-153.
PMID: 36760748 PMC: 9890587. DOI: 10.1039/d2md00330a.
Abdoli M, Bonardi A, Supuran C, Zalubovskis R J Enzyme Inhib Med Chem. 2023; 38(1):2152811.
PMID: 36629134 PMC: 9848269. DOI: 10.1080/14756366.2022.2152811.